Analysis and interpretation of drug testing results from patients on chronic pain therapy: A clinical laboratory perspective

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 8, 2009, Pages 971-976

  Melanson, Stacy E F ^a   Kredlow, Maria I ^a   Jarolim, Petr ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Chronic pain; Clinical laboratory; Opioids; Pain clinic; Urine drug testing

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; COCAINE; CODEINE; DEXTROPROPOXYPHENE; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; MORPHINE 6 ACETATE; OPIATE; OXYCODONE; OXYMORPHONE; PHENCYCLIDINE; TETRAHYDROCANNABINOL; TRAMADOL;

ARTICLE; CHRONIC PAIN; DRUG ABUSE; DRUG SCREENING; DRUG URINE LEVEL; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL;

ANALGESICS, OPIOID; CHRONIC DISEASE; DRUG MONITORING; DRUG PRESCRIPTIONS; HUMANS; PAIN; PATIENT COMPLIANCE; PRACTICE GUIDELINES AS TOPIC; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 70349501460     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.220     Document Type: Article

References (13)

1. Trescot AM, Boswell MV, Atluri SL, Hansen HC, Deer TR, Abdi S, et al. Opioid guidelines in the management of chronic non-cancer pain. Pain Physician 2006;9:1-39.
2. Heit HA, Gourlay DL. Urine drug testing in pain medicine. J Pain Symptom Manage 2004;27:260-267
3. Ives TJ, Chelminski PR, Hammett-Stabler CA, Malone RM, Perhac JS, Potisek NM, et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res 2006;6:46.
4. Katz N, Fanciullo GJ. Role of urine toxicology testing in the management of chronic opioid therapy. Clin J Pain 2002;18:S76-82.
5. Katz NP, Sherburne S, Beach M, Rose RJ, Vielguth J, Bradley J, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg 2003;97:1097-1102
6. Manchikanti L, Cash KA, Damron KS, Manchukonda R, Pampati V, McManus CD. Controlled substance abuse and illicit drug use in chronic pain patients: an evaluation of multiple variables. Pain Physician 2006;9:215-225
7. Manchikanti L, Manchukonda R, Pampati V, Damron KS, Brandon DE, Cash KA, et al. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids? Pain Physician 2006;9:123-129
8. Michna E, Jamison RN, Pham LD, Ross EL, Janfaza D, Nedeljkovic SS, et al. Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings. Clin J Pain 2007;23: 173-179
9. Bhamb B, Brown D, Hariharan J, Anderson J, Balousek S, Fleming MF. Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin 2006;22:1859-1865
10. Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Heard SE. 2007 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 25th Annual Report. Clin Toxicol (Phila) 2008;46:927-1057.
11. Hammett-Stabler CA, Pesce AJ, Cannon DJ. Urine drug screening in the medical setting. Clin Chim Acta 2002; 315:125-135
12. Wu AH, McKay C, Broussard LA, Hoffman RS, Kwong TC, Moyer TP, et al. National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin Chem 2003;49:357-379
13. Nafziger AN, Bertino JS Jr. Utility and application of urine drug testing in chronic pain management with opioids. Clin J Pain 2009;25:73-79